Search
forResearch 10 of 106
- Semaglutide Treatment of Excessive Body Weight in Obese PCOS Patients Unresponsive to Lifestyle Programs
- Alopecia and Semaglutide: Connecting the Dots for Patient Safety
- Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review
- New-Onset Alopecia Is Significantly Higher with Tirzepatide than with Semaglutide, Even After Weight-Loss Matching
- Semaglutide and the Skin: An Overview of Current Evidence
- Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report
- 53028 Semaglutide and Hair Loss: A Real-World Analysis
- Semaglutide as a Cornerstone Therapy in Obesity: Clinical and Pharmacological Insights
- Semaglutide-associated worsening of atypical anorexia nervosa in an adolescent girl: case report
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
Community 1
Learn
— no results
Try a deeper search in learn →